27580 results about "Potassium" patented technology

A sensor is disclosed, for implantation within a blood vessel to monitor a substance in or property of blood. In one embodiment, the sensor detects nitric oxide or a nitric oxide metabolite. In another embodiment, other substances such as glutamate, aspartate, arginine, citrulline, acetylcholine, calcium, potassium, or dopamine are monitored. The sensor may be attached to a support structure such as a stent, guidewire, or catheter. In a further embodiment, a catheter is disclosed that extracts patient fluid to a sensor outside the body for monitoring a substance or property of the patient fluid. Methods are also disclosed.

This invention includes pharmaceutical compositions, methods and kits for the treatment or diagnosis of a malignant tumors, including brain tumors, and diseases or disorders characterized by abnormal brain tissue.

The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and/or the use of hyperkalemia causing drugs.

Provided are immediate or prolonged administration of certain potassium ATP (K_ATP) channel openers to a subject to achieve novel pharmacodynamic, pharmacokinetic, therapeutic, physiological, metabolic and compositional outcomes in the treatment of diseases or conditions involving K_ATP channels. Also provided are pharmaceutical formulations, methods of administration and dosing of K_ATP channel openers that achieve these outcomes and reduce the incidence of adverse effects in treated individuals. Further provided are method of co-administering K_ATP channel openers with other drugs to treat diseases of humans and animals.

The invention encompasses novel salts of topiramate, and pharmaceutically acceptable polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, or amorphous forms thereof, as well as pharmaceutical compositions and pharmaceutical unit dosage forms containing the same. In particular, the invention encompasses pharmaceutically acceptable salts of topiramate, including without limitation topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms thereof. The invention further encompasses novel co-crystals or complexes of topiramate, as well as pharmaceutical compositions comprising them. The invention also encompasses methods of treating or preventing a variety of diseases and conditions including, but not limited to, seizures, epileptic conditions, tremors, cerebral function disorders, obesity, neuropathic pain, affective disorders, tobacco cessation, migraines, and cluster headache.

The invention discloses a particle-typed composite fertilizer of humic acid and manufacturing method, which consists of dressing and karyosome, wherein the dressing contains nitrogen, phosphor and potassium. The manufacturing method comprises the following steps: graining humic acid; cladding; graining; solidifying fused fertilizer on the particle of humic acid; making the composite fertilizer dissolved into water without falling; fitting for large scale of agricultural product.

The present invention provides biological fertilizer compositions that comprise yeast cells that have an enhanced ability to fix atmospheric nitrogen, decompose phosphorus minerals and compounds, decompose potassium minerals and compounds, decompose complex carbon compounds, over produce growth factors, and over produce ATP. The biological fertilizer composition of the invention can replace mineral fertilizers in supplying nitrogen, phosphorus, and potassium to crop plants. Methods of manufacturing the biological fertilizer compositions and methods of uses are also encompassed.

Metabolic energy capacity enhancing compositions and methods for reducing oxidative stress and improving vitality in a mammal are disclosed. A composition for increasing metabolic energy capacity may be in a palatable liquid formulation or a solid dosage form and typically includes an anti-oxidant containing phytonectar and an energy catalyst. An anti-oxidant may include a polyphenol, anthrocyanin, bioflavonoid, proanthocyanidin, and a xanthone. An energy catalyst may include a mineral, vitamin, co-vitamin, carbohydrate and a lipid. In a presently preferred embodiment a composition includes phytonectar extracts from grape, aloe vera, apple, morinda citrifolia, scullcap, blueberry, prune, cranberry, elderberry, bilberry, and gentain and a mineral blend containing calcium, magnesium, manganese, zinc, chromium, selenium, iron, copper, molybdenum, vanadium, potassium, iodine, and cobalt. A method for increasing metabolic energy capacity in a mammal may include consuming a chemical component having the ability to undergo oxidation, producing free radicals and administering a composition having an anti-oxidant containing phytonectar and an energy catalyst.

The present invention relates to a blood analyte measurement system for the procurement of blood samples for measurement of blood properties such as analyte concentration or analyte presence. A blood access system can be coupled with a measurement system such as an electrochemical sensor, and can also be used with other measurement modalities. Embodiments of the present invention can facilitate accurate measurement of blood glucose by the clinician in a sterile manner. Embodiments of the present invention can also enable the calibration of the sensor at one or more calibration points. One desired analyte of measurement is glucose for the effective implementation of glycemic control protocols. Embodiments of the present invention can also be used for the measurement of other analytes such as arterial blood gases, lactate, hemoglobin, potassium and urea. Additionally, embodiments of the present invention can function effectively on a variety of blood access points and specifically enables glucose monitoring in an existing arterial line that is already in place for hemodynamic monitoring. The present invention does not consume a significant amount of blood. Some embodiments of the present invention can re-infuse the blood into the patient, which can facilitate operation of the system in a sterile manner.

Platelet suspensions and methods for resuspending platelet concentrates are disclosed. The platelet concentrates are resuspended by combining a platelet concentrate with a hypertonic solution of either sodium chloride or potassium chloride. The resuspended platelets may be stored and/or administered to a patient.

The invention relates to a modified copolyester slice or fiber and a relative preparation, wherein the slice is copolymerized from terephthalic acid, ethandiol, isophthalate esters of sulfonic acid sodium (or potassium), and fatty group dibasic alcohol (or relative alkylate) with side chain. And the preparation comprises that (1), mixing the ethandiol and the fatty group dibasic alcohol (or relative alkylate) into a mixed alcohol, adding catalyzer and stabilizer to esterify the terephthalic acid under 220-260Deg. C, (2), adding 1-9%mol isophthalate esters of sulfonic acid sodium (or potassium) relative to the terephthalic acid for polycondensation at 250-300Deg. C, (3), drying, fusing, spinning, and drawing to obtain the modified copolyester filament. The inventive product can dye anion paint and disperse paint into deep color at normal pressure, with better feeling, high contraction, hidden micro coiled property, simple preparation, low cost and batch production support.

The present invention relates to a selective hydro-desulfurization catalyst of gasoline and process for using said catalyst. Said invented catayst uses alumina as carrier, uses molybdenum and cobalt as active component, at the same time contains adjuvant potassium and phosphorus, and the optimized atomic ratio of phosphorus and potassium is 1-2. Said invented catalyst has good selectivity and stability, and at the same time has proper activity, and is mainly used for selective hydro-desulfurization of catalytic cracked gasoline.

A composition suitable for use as a cathode material of a lithium battery includes a core material having an empirical formula Li_xM′_zNi_1−yM″_yO₂. “x” is equal to or greater than about 0.1 and equal to or less than about 1.3. “y” is greater than about 0.0 and equal to or less than about 0.5. “z” is greater than about 0.0 and equal to or less than about 0.2. M′ is at least one member of the group consisting of sodium, potassium, nickel, calcium, magnesium and strontium. M″ is at least one member of the group consisting of cobalt, iron, manganese, chromium, vanadium, titanium, magnesium, silicon, boron, aluminum and gallium. A coating on the core has a greater ratio of cobalt to nickel than the core. The coating and, optionally, the core can be a material having an empirical formula Li_x1A_x2Ni_1−y1−z1Co_y1B_z1O_a. “x1” is greater than about 0.1 a equal to or less than about 1.3. “x2,”“y1” and “z1” each is greater than about 0.0 and equal to or less than about 0.2. “a” is greater than 1.5 and less than about 2.1. “A” is at least one element selected from the group consisting of barium, magnesium, calcium and strontium. “B” is at least one element selected from the group consisting of boron, aluminum, gallium, manganese, titanium, vanadium and zirconium.

Advantageous aqueous mixed salt systems viscosified with water-soluble or water-dispersable polymers which are superior to corresponding single salt systems of similar densities are provided. The mixed salt systems comprise water; a water-soluble or water-dispersable polymer capable of viscosifying an aqueous medium; one or more cations including a member selected from the group consisting of lithium, sodium, potassium, cesium, magnesium, calcium, zinc, or mixtures thereof; and one or more anions including a member selected from the group consisting of chloride, bromide, iodide, formate, nitrate, acetate, cyanate, thiocyanate, a zinc complex anion or mixtures thereof; there being present either at least two cations or at least two anions. Inventive viscosified mixed salt systems display-under such stressing factors as aging, heat, mechanical agitation, and shear-greater stability compared to the single salt systems of similar densities. Also provided are methods for making viscosified mixed salt systems and methods for advantageously using the same as drilling, drill-in, completion, hydraulic fracturing, work-over, packer, well treating, testing, spacer, or hole abandonment fluids.

Sulfonate salts have the formula: CF₃—CH(OCOR)—CF₂SO₃⁻M⁺ wherein R is C₁-C₂₀ alkyl or C₆-C₁₄ aryl, and M⁺ is a lithium, sodium, potassium, ammonium or tetramethylammonium ion. Onium salts, oximesulfonates and sulfonyloxyimides and other compounds derived from these sulfonate salts are effective photoacid generators in chemically amplified resist compositions.

A nitrogen oxide storage material is disclosed which contains at least one storage component for nitrogen oxides in the form of an oxide, mixed oxide, carbonate or hydroxide of the alkaline earth metals magnesium, calcium, strontium and barium and the alkali metals potassium and caesium on a high surface area support material. The support material can be doped cerium oxide, cerium/zirconium mixed oxide, calcium titanate, strontium titanate, barium titanate, barium stannate, barium zirconate, magnesium oxide, lanthanum oxide, praseodymium oxide, samarium oxide, neodymium oxide, yttrium oxide, zirconium silicate, yttrium barium cuprate, lead titanate, tin titanate, bismuth titanate, lanthanum cobaltate, lanthanum manganate and barium cuprate or mixtures thereof.

The invention is a hard capsule comprising pullulan in an amount of 85% to 90% by weight, potassium chloride in an amount of 1.0% to 1.5% by weight, carrageenan in an amount of 0.1% to 0.4% by weight, one or more surfactants in an amount of 0.1% to 0.2% by weight and water in an amount of 10% to 15% by weight. Additionally the invention is related to new uses of pullulan containing containers.

The present invention provides for the preparation of ionic liquid-lithium salt-low molecular weight liquid polymer mixtures. The mixture is useful as an electrolytic solution. Thus, the mixture is suitable as an electrolyte in batteries and supercapacitors as well as an active material for solid state light-emitting devices or polymer light-emitting displays or an electro deposition of alkali metals such as lithium, sodium, or potassium in the field of research or industry. The present invention further provides for a method making the mixture. Additionally, the present invention provides for a lithium battery comprising the mixture and a method of making the lithium battery.

A method and device for removing, deodorizing and purifying odor, smoke and harmful substances from exhaust gas or flue gas employs a water solution containing hypohalogen acid such as hypochlorous acid soda, an alkaline electrolyte such as potassium hydroxide or sodium hydroxide and a saline electrolyte such as sodium chloride, potassium chloride, sodium bromide or potassium bromide which is electrolyzed to produce an electrolytic water solution which is fed to a deodorizing tower and brought into contact with exhaust gas or flue gas to remove odor, smoke and harmful substances in the exhaust gas or flue gas.